BeiGene, Ltd. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2016 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
BeiGene, Ltd. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2016 to Q2 2024.
  • BeiGene, Ltd. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 1.36B shares, a 0.06% increase year-over-year.
  • BeiGene, Ltd. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 1.36B shares, a 1.22% increase from 2022.
  • BeiGene, Ltd. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 1.34B shares, a 11.2% increase from 2021.
  • BeiGene, Ltd. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 1.21B shares, a 11.2% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 1.36B +858K +0.06% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 1.36B +1.38M +0.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 1.36B +16.3M +1.22% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-26
Q3 2023 1.36B +15.4M +1.15% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 1.36B +23.8M +1.78% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 1.35B +22.1M +1.66% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 1.34B +135M +11.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-26
Q3 2022 1.35B +139M +11.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 1.34B +142M +11.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 1.33B +143M +12% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 1.21B +121M +11.2% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-26
Q3 2021 1.21B +57M +4.96% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 1.19B +184M +18.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 1.19B +184M +18.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 1.09B Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 1.15B Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 1.01B Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 1.01B Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q3 2018 740M +192M +35.1% Jul 1, 2018 Sep 30, 2018 10-Q 2018-11-08
Q3 2017 548M +119M +27.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q3 2016 428M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.